NanoViricides enters into at-the-market sales agreement with D. Boral Capital for common stock offering

NANOVIRICIDES, INC.

Company entered into an At Market Issuance Sales Agreement with D. Boral Capital LLC for at-the-market sales of common stock.
Sales agent commission set at 2.0% of gross proceeds from each sale.
Shares may be sold on NYSE American or other trading markets; no minimum amount specified.
Agreement terminates upon sale of all shares or termination by either party.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.